Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers F > Headlines for Forest Laboratories, Inc. > News item |
Forest Laboratories at hold: Jefferies
Forest Laboratories Inc. was rated hold with a $40.00 price target by Jefferies & Co., Inc. analysts David H. Windley and Himanshu Rastogi. They noted the company appears on track to meet Jefferies' sales forecast and Forest's main products, Lexapro, Namenda and Benicar, have achieved 32% of its prescription forecast thus far. Forest shares closed Thursday up $0.45, or 1.08%, at $42.10 on volume of 2,956,300 shares compared to a three-month trailing average of 1,585,520 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.